수술용 로봇 시장 : 제공 제품별, 용도별, 최종사용자별, 지역별 - 예측(-2030년)

The global surgical robots market is projected to reach USD 27.14 billion by 2030 from USD 13.69 billion in 2025, at a CAGR of 14.7% during the forecast period.

The surgical robots market is experiencing strong growth as healthcare providers increasingly adopt robotic-assisted systems to enhance surgical precision, improve patient outcomes, and support minimally invasive procedures. The rising demand for faster recovery, reduced complications, and shorter hospital stays is driving hospitals to invest in robotics across multiple specialties. Continuous technological advancements, such as improved imaging, AI-driven guidance, and more compact robotic platforms, are expanding the clinical applications of robotic surgery. At the same time, the growth of surgeon training programs, supportive reimbursement structures, and increased patient awareness are accelerating adoption. Together, these factors are pushing the market forward and broadening the global footprint of robotic-assisted surgery.

"By offering, the instruments & accessories segment held the largest market share in 2024."

The instruments & accessories segment accounts for the largest share of the surgical robots market because these components are required for every robotic procedure, creating steady and recurring demand. While robotic systems are a one-time capital investment, instruments such as staplers, scissors, graspers, energy devices, and other consumables must be replaced after a limited number of uses, ensuring continuous utilization and revenue. Accessories, such as vision tools, ports, and trocars, are also essential for system functionality and require frequent replenishment. As robotic procedure volumes continue to rise and hospitals expand their robotic programs, the consumption of instruments and accessories grows proportionally, making this segment the most significant contributor to overall market revenue.

"By end user, the hospitals & clinics segment accounted for the largest market share in 2024."

Hospitals & clinics dominate the surgical robots market because they are the primary locations where surgeries are performed and have the necessary facilities, financial resources, and trained personnel to adopt robotic technologies. These institutions invest in robotics to improve surgical precision, enhance patient outcomes, and streamline clinical workflows. Favorable reimbursement policies for minimally invasive procedures further support their adoption of robotic systems. Additionally, most surgeons undergo robotic training within hospital environments, which increases utilization. With growing patient expectations for advanced, minimally invasive care, hospitals & clinics continue to be the largest and most influential end users in the market.

"The US is expected to grow at the highest CAGR during the forecast period."

The US is expected to grow at the highest CAGR within the North American surgical robots market due to its strong focus on adopting advanced medical technologies, rapid expansion of robotic-assisted surgical programs, and continuous investments in hospital infrastructure. The country benefits from a large base of trained surgeons, extensive clinical research activity, and high patient demand for minimally invasive procedures, all of which accelerate the uptake of robotic platforms. Favorable reimbursement policies, a strong presence of leading robotic surgery manufacturers, and ongoing product innovations further support growth. Additionally, the US healthcare system's emphasis on improving patient outcomes, reducing hospital stays, and enhancing surgical precision continues to drive faster adoption of surgical robots compared to other countries in the region.

A breakdown of the primary participants (supply side) for the surgical robots market referred to in this report is provided below:

• By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
• By Designation: C-level Executives (45%), Director-level Executives (35%), and Others (20%)
• By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)

Prominent players in the surgical robots market are Intuitive Surgical (US), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), Zimmer Biomet (US), Asensus Surgical (US), Siemens Healthineers (Germany), CMR Surgical (UK), Johnson & Johnson (US), and Renishaw Plc (UK).

Research Coverage:

The report analyzes the surgical robots market and aims at estimating the market size and future growth potential of this market based on various segments such as offering, application, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall surgical robots market. This report will help stakeholders understand the competitive landscape and gain valuable insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market, providing them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (advantages of robot-assisted surgery, technological advancements, improving reimbursement scenario, increasing adoption of surgical robots, and increasing funding for medical robot research), restraints (high cost of robotic systems), opportunities (increasing penetration of surgical robots in ASCs and growth opportunities in emerging markets), and challenges (surgical errors).
• Market Penetration: It includes extensive information on products offered by the major players in the global surgical robots market. The report includes various segments by offering, application, end user, and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global surgical robots market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by offering, application, end user, and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global surgical robots market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global surgical robots market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
• 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 MARKET OVERVIEW

• 3.1 INTRODUCTION
  • 3.1.1 DRIVERS
    • 3.1.1.1 Advantages of robot-assisted minimally invasive surgeries
    • 3.1.1.2 Technological advancements in surgical robots
    • 3.1.1.3 Improving reimbursement scenario for surgical robots
    • 3.1.1.4 Increasing adoption of surgical robots in modern surgeries
    • 3.1.1.5 Increasing funding for medical robot research
  • 3.1.2 RESTRAINTS
    • 3.1.2.1 High cost of robotic systems
  • 3.1.3 OPPORTUNITIES
    • 3.1.3.1 Increasing penetration of surgical robots in outpatient settings
    • 3.1.3.2 High growth opportunities in emerging economies
  • 3.1.4 CHALLENGES
    • 3.1.4.1 Rising number of surgical errors in global healthcare systems
• 3.2 UNMET NEEDS & WHITE SPACES
  • 3.2.1 UNMET NEEDS IN SURGICAL ROBOTS MARKET
  • 3.2.2 WHITE SPACE OPPORTUNITIES
• 3.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 3.3.1 INTERCONNECTED MARKETS
  • 3.3.2 CROSS-SECTOR OPPORTUNITIES
• 3.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

4 INDUSTRY TRENDS

• 4.1 PORTER'S FIVE FORCES ANALYSIS
  • 4.1.1 THREAT OF NEW ENTRANTS
  • 4.1.2 THREAT OF SUBSTITUTES
  • 4.1.3 BARGAINING POWER OF SUPPLIERS
  • 4.1.4 BARGAINING POWER OF BUYERS
  • 4.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 4.2 MACROECONOMIC OUTLOOK
  • 4.2.1 INTRODUCTION
  • 4.2.2 GDP TRENDS AND FORECAST
  • 4.2.3 TRENDS IN GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY
  • 4.2.4 TRENDS IN GLOBAL MEDICAL ROBOTS INDUSTRY
• 4.3 SUPPLY CHAIN ANALYSIS
• 4.4 VALUE CHAIN ANALYSIS
• 4.5 ECOSYSTEM ANALYSIS
• 4.6 PRICING ANALYSIS
  • 4.6.1 AVERAGE SELLING PRICE OF SURGICAL ROBOTIC APPLICATIONS, BY KEY PLAYER, 2024
  • 4.6.2 AVERAGE SELLING PRICE TREND OF SURGICAL ROBOTS, BY REGION, 2022-2024
• 4.7 TRADE DATA ANALYSIS
  • 4.7.1 IMPORT DATA FOR HS CODE 901890
  • 4.7.2 EXPORT DATA FOR HS CODE 901890
• 4.8 KEY CONFERENCES AND EVENTS, 2025-2026
• 4.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 4.10 INVESTMENT AND FUNDING SCENARIO
• 4.11 CASE STUDY ANALYSIS
  • 4.11.1 REVOLUTIONISING FUTURE OF SURGERY WITH HIGH-PRECISION ROBOTS
  • 4.11.2 HUNJAN HOSPITAL DEPLOYS ORTHOPEDIC SURGICAL ROBOT FOR KNEE REPLACEMENT SURGERY
  • 4.11.3 BIONAUT LABS CREATES REMOTE-CONTROLLED MICRO-ROBOTS TO TARGET BRAIN DISEASES
• 4.12 IMPACT OF 2025 US TARIFF ON SURGICAL ROBOTS MARKET
  • 4.12.1 KEY TARIFF RATES
  • 4.12.2 PRICE IMPACT ANALYSIS
  • 4.12.3 IMPACT ON COUNTRY/REGION
    • 4.12.3.1 North America
      • 4.12.3.1.1 US
    • 4.12.3.2 Europe
    • 4.12.3.3 Asia Pacific
  • 4.12.4 IMPACT ON END-USE INDUSTRIES

5 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 5.1 KEY EMERGING TECHNOLOGIES
  • 5.1.1 ROBOTIC ARMS AND INSTRUMENTS
  • 5.1.2 ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML)
  • 5.1.3 TELEPRESENCE
  • 5.1.4 5G TECHNOLOGY
  • 5.1.5 COMPLEMENTARY TECHNOLOGIES
    • 5.1.5.1 Augmented reality (AR) and virtual reality (VR)
    • 5.1.5.2 3D printing
• 5.2 TECHNOLOGY/PRODUCT ROADMAP
  • 5.2.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
  • 5.2.2 MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION
  • 5.2.3 LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
• 5.3 PATENT ANALYSIS
• 5.4 FUTURE APPLICATIONS OF SURGICAL ROBOTS
• 5.5 IMPACT OF AI/GEN AI ON SURGICAL ROBOTS MARKET
  • 5.5.1 TOP USE CASES AND MARKET POTENTIAL
  • 5.5.2 BEST PRACTICES IN SURGICAL ROBOTS PROCESSING
  • 5.5.3 CASE STUDIES OF AI IMPLEMENTATION
  • 5.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • 5.5.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI

6 REGULATORY LANDSCAPE

• 6.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 6.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.1.2 REGULATORY FRAMEWORK
    • 6.1.2.1 North America
      • 6.1.2.1.1 US
    • 6.1.2.2 Europe
    • 6.1.2.3 Asia Pacific
      • 6.1.2.3.1 Japan
      • 6.1.2.3.2 China
      • 6.1.2.3.3 India
  • 6.1.3 INDUSTRY STANDARDS
• 6.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 7.1 DECISION-MAKING PROCESS
• 7.2 KEY STAKEHOLDERS & BUYING EVALUATION CRITERIA
  • 7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 7.2.2 KEY BUYING CRITERIA
• 7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 7.4 UNMET NEEDS FROM END-USE INDUSTRIES
• 7.5 MARKET PROFITABILITY
  • 7.5.1 REVENUE POTENTIAL
  • 7.5.2 COST DYNAMICS
  • 7.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

8 SURGICAL ROBOTS MARKET, BY OFFERING

• 8.1 INTRODUCTION
• 8.2 INSTRUMENTS & ACCESSORIES
  • 8.2.1 NEED FOR RECURRENT PURCHASE OF INSTRUMENTS & ACCESSORIES TO DRIVE MARKET GROWTH
• 8.3 ROBOTIC SYSTEMS
  • 8.3.1 LAPAROSCOPIC ROBOTIC SYSTEMS
    • 8.3.1.1 Growing popularity of laparoscopic robotic surgeries to drive market
  • 8.3.2 ORTHOPEDIC ROBOTIC SYSTEMS
    • 8.3.2.1 Rising number of market players offering orthopedic robots to support market growth
  • 8.3.3 NEUROSURGICAL ROBOTIC SYSTEMS
    • 8.3.3.1 Better reproducibility, higher accuracy, and greater precision in long, narrow surgical corridors to support market growth
  • 8.3.4 OTHER ROBOTIC SYSTEMS
• 8.4 SERVICES
  • 8.4.1 ONGOING NEED FOR SERVICE CONTRACTS FOR FUNDAMENTAL OPERATIONS TO PROPEL MARKET GROWTH

9 SURGICAL ROBOTS MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 GENERAL SURGERY
  • 9.2.1 GROWING PREFERENCE FOR ROBOT-ASSISTED GENERAL SURGICAL PROCEDURES TO DRIVE MARKET
• 9.3 GYNECOLOGICAL SURGERY
  • 9.3.1 RISING NUMBER OF HYSTERECTOMIES TO INCREASE DEMAND FOR SURGICAL ROBOTS
• 9.4 ORTHOPEDIC SURGERY
  • 9.4.1 GROWING PREFERENCE FOR KNEE RECONSTRUCTION PROCEDURES TO SUPPORT MARKET GROWTH
• 9.5 UROLOGICAL SURGERY
  • 9.5.1 RISING PREVALENCE OF UROLOGICAL DISEASES TO FUEL DEMAND FOR SURGICAL ROBOTS
• 9.6 NEUROSURGERY
  • 9.6.1 INCREASING USE OF ROBOTIC TECHNOLOGIES IN NEUROSURGICAL PROCEDURES TO DRIVE MARKET
• 9.7 MICROSURGERY
  • 9.7.1 RISING INTERSECTION OF MINIMALLY INVASIVE SURGERY AND SURGICAL ROBOTS TO SUPPORT MARKET GROWTH
• 9.8 OTOLOGICAL SURGERY
  • 9.8.1 RISING PREVALENCE OF EAR-RELATED DISORDERS TO SPUR MARKET GROWTH
• 9.9 OTHER APPLICATIONS

10 SURGICAL ROBOTS MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOSPITALS & CLINICS
  • 10.2.1 INCREASING ROBOTIC-ASSISTED SURGERIES TO PROPEL MARKET GROWTH
• 10.3 AMBULATORY SURGERY CENTERS
  • 10.3.1 GROWING PATIENT PREFERENCE FOR COST-EFFECTIVE TREATMENTS TO DRIVE MARKET GROWTH

11 SURGICAL ROBOTS MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 US
    • 11.2.1.1 US to dominate North American surgical robots market during study period
  • 11.2.2 CANADA
    • 11.2.2.1 Increased adoption of surgical robots for gynecological surgeries and cancerous tumor removal to drive market
• 11.3 EUROPE
  • 11.3.1 GERMANY
    • 11.3.1.1 Favorable healthcare initiatives and large pool of stroke patients to spur market growth
  • 11.3.2 UK
    • 11.3.2.1 Rising investments in surgical robots to propel market growth
  • 11.3.3 FRANCE
    • 11.3.3.1 Favorable investments and high demand for surgical robotic systems to boost market growth
  • 11.3.4 SPAIN
    • 11.3.4.1 Increasing number of robotic-assisted surgical procedures and initiatives to fuel growth
  • 11.3.5 ITALY
    • 11.3.5.1 Increasing number of robotic surgical procedures to propel market growth
  • 11.3.6 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 JAPAN
    • 11.4.1.1 Favorable government initiatives to support adoption of surgical robots
  • 11.4.2 CHINA
    • 11.4.2.1 Favorable government initiatives to boost market growth
  • 11.4.3 INDIA
    • 11.4.3.1 Rapid developments in healthcare infrastructure to support market growth
  • 11.4.4 AUSTRALIA
    • 11.4.4.1 Increasing implementation and development of s urgical robotic training programs to fuel market growth
  • 11.4.5 SOUTH KOREA
    • 11.4.5.1 Increasing installation of surgical robots and growing government investments to ensure steady market growth
  • 11.4.6 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 BRAZIL
    • 11.5.1.1 Rising incidence of target diseases and growing healthcare expenditure to drive market
  • 11.5.2 MEXICO
    • 11.5.2.1 Growing emphasis on surgical robotics in healthcare to support market growth
  • 11.5.3 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 GCC COUNTRIES
    • 11.6.1.1 Robust healthcare industry and favorable government strategies to drive market
  • 11.6.2 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 INTRODUCTION
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SURGICAL ROBOTS MARKET
• 12.3 REVENUE ANALYSIS, 2020-2024
• 12.4 MARKET SHARE ANALYSIS, 2024
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Offering footprint
    • 12.5.5.4 Application footprint
    • 12.5.5.5 End-user footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 DYNAMIC COMPANIES
  • 12.6.3 STARTING BLOCKS
  • 12.6.4 RESPONSIVE COMPANIES
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 12.6.5.1 Detailed list of key startups/SMEs
    • 12.6.5.2 Competitive benchmarking of key startups/SMEs
• 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.7.1 FINANCIAL METRICS
  • 12.7.2 COMPANY VALUATION
• 12.8 BRAND/PRODUCT COMPARISON
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT/SERVICE LAUNCHES AND APPROVALS
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 INTUITIVE SURGICAL OPERATIONS, INC.
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Services/Solutions offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product approvals
      • 13.1.1.3.2 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 STRYKER
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Services/Solutions offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches
      • 13.1.2.3.2 Deals
      • 13.1.2.3.3 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses & competitive threats
  • 13.1.3 ZIMMER BIOMET
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Services/Solutions offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product approvals
      • 13.1.3.3.2 Deals
      • 13.1.3.3.3 Other developments
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 MEDTRONIC
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Services/Solutions offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product approvals
      • 13.1.4.3.2 Deals
      • 13.1.4.3.3 Expansions
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses & competitive threats
  • 13.1.5 SMITH+NEPHEW
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Services/Solutions offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product & service launches and enhancements
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses & competitive threats
  • 13.1.6 ASENSUS SURGICAL US, INC.
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Services/Solutions offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product approvals
      • 13.1.6.3.2 Deals
  • 13.1.7 SIEMENS HEALTHINEERS AG
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Services/Solutions offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Deals
  • 13.1.8 RENISHAW PLC
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Services/Solutions offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product approvals
  • 13.1.9 GLOBUS MEDICAL
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Services/Solutions offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product approvals
  • 13.1.10 JOHNSON & JOHNSON
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Services/Solutions offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product approvals
  • 13.1.11 CMR SURGICAL LTD.
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Services/Solutions offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Product approvals
      • 13.1.11.3.2 Deals
      • 13.1.11.3.3 Expansions
      • 13.1.11.3.4 Other developments
  • 13.1.12 THINK SURGICAL, INC.
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products/Services/Solutions offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Product approvals
      • 13.1.12.3.2 Deals
  • 13.1.13 CORIN GROUP
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products/Services/Solutions offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Product launches & approvals
  • 13.1.14 MICROSURE
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products/Services/Solutions offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Other developments
  • 13.1.15 AVATERAMEDICAL GMBH
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products/Services/Solutions offered
  • 13.1.16 MEDICAL MICROINSTRUMENTS, INC.
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products/Services/Solutions offered
    • 13.1.16.3 Recent developments
      • 13.1.16.3.1 Product approvals
      • 13.1.16.3.2 Deals
      • 13.1.16.3.3 Other developments
  • 13.1.17 MEDICAROID CORPORATION
    • 13.1.17.1 Business overview
    • 13.1.17.2 Products/Services/Solutions offered
    • 13.1.17.3 Recent developments
      • 13.1.17.3.1 Product approvals
      • 13.1.17.3.2 Deals
  • 13.1.18 BRAINLAB SE
    • 13.1.18.1 Business overview
    • 13.1.18.2 Products/Services/Solutions offered
    • 13.1.18.3 Recent developments
      • 13.1.18.3.1 Product approvals
      • 13.1.18.3.2 Deals
  • 13.1.19 ECENTIAL ROBOTICS
    • 13.1.19.1 Business overview
    • 13.1.19.2 Products/Services/Solutions offered
    • 13.1.19.3 Recent developments
      • 13.1.19.3.1 Product approvals
      • 13.1.19.3.2 Deals
  • 13.1.20 SS INNOVATIONS INTERNATIONAL, INC.
    • 13.1.20.1 Business overview
    • 13.1.20.2 Products/Services/Solutions offered
    • 13.1.20.3 Products/Services/Solutions in pipeline
    • 13.1.20.4 Recent developments
      • 13.1.20.4.1 Product launches and approvals
    • 13.1.20.5 MnM view
      • 13.1.20.5.1 Right to win
      • 13.1.20.5.2 Strategic choices
      • 13.1.20.5.3 Weaknesses & competitive threats
• 13.2 OTHER PLAYERS
  • 13.2.1 MONTERIS
  • 13.2.2 MOMENTIS INNOVATIVE SURGERY
  • 13.2.3 TINAVI MEDICAL TECHNOLOGIES CO., LTD.
  • 13.2.4 DISTALMOTION SA
  • 13.2.5 NOVUS SAGLIK URUNLERI AR-GE DANISMANLIK (NOVUS ARGE)

14 RESEARCH METHODOLOGY

• 14.1 RESEARCH DATA
  • 14.1.1 SECONDARY DATA
    • 14.1.1.1 Key sources of secondary data
    • 14.1.1.2 Key data from secondary sources
  • 14.1.2 PRIMARY DATA
    • 14.1.2.1 Key objectives of primary research
    • 14.1.2.2 Key data from primary sources
    • 14.1.2.3 Key industry insights
• 14.2 MARKET SIZE ESTIMATION
  • 14.2.1 BOTTOM-UP APPROACH
  • 14.2.2 TOP-DOWN APPROACH
  • 14.2.3 BASE NUMBER ESTIMATION
    • 14.2.3.1 Supply-side analysis (revenue share analysis)
    • 14.2.3.2 Company presentations and primary interviews
• 14.3 MARKET FORECAST APPROACH
• 14.4 DATA TRIANGULATION
• 14.5 STUDY ASSUMPTIONS
  • 14.5.1 MARKET SHARE ASSUMPTIONS
  • 14.5.2 RESEARCH ASSUMPTIONS
• 14.6 FACTOR ANALYSIS
• 14.7 RISK ANALYSIS
• 14.8 RESEARCH LIMITATIONS

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS